Of 631 LAM patients, 486 (77.02%) patients were diagnosed based on positive VEGF-D level on enrolment, and 41 (6.498%) patients were diagnosed based on elevated VEGF-D level before enrolment. The gene discussed is VEGFD; the disease is lymphangioleiomyomatosis.